BioCentury | Aug 6, 2020
Management Tracks

Kindler joins Blackstone as senior adviser; plus changes at Mission, Annexon, Dyne, Ribometrix, Autolus and more

...He serves as EVP, head of R&D at Acceleron Pharma Inc. (NASDAQ:XLRN). Hematologic diseases company Disc Medicine Inc....
...Sangamo Therapeutics Inc. (NASDAQ:SGMO). Robin Sawka, BioCentury Staff Blackstone Group Ribometrix Inc. Dyne Therapeutics Inc. Annexon Inc. Mission Therapeutics Ltd. Autolus Therapeutics plc Disc Medicine Inc. Akouos...
BioCentury | Jan 29, 2020
Company News

Management tracks: Century Therapeutics, Passage, Forbion, Bavarian, Disc, Biocartis, QuantuMDx and more

...Zika and norovirus vaccines at the vaccine unit of Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK). Disc Medicine Inc....
BioCentury | Oct 30, 2019
Emerging Company Profile

Disc Medicine: Seeking Iron Balance via Hepcidin

...round with participation by Access Biotechnology and founding investing Atlas Venture, which seeded Cambridge, Mass.-based Disc Medicine Inc....
...data for the two programs, which each represent multibillion dollar opportunities, Bitterman said. COMPANY PROFILE Disc Medicine Inc....
Items per page:
1 - 3 of 3
BioCentury | Aug 6, 2020
Management Tracks

Kindler joins Blackstone as senior adviser; plus changes at Mission, Annexon, Dyne, Ribometrix, Autolus and more

...He serves as EVP, head of R&D at Acceleron Pharma Inc. (NASDAQ:XLRN). Hematologic diseases company Disc Medicine Inc....
...Sangamo Therapeutics Inc. (NASDAQ:SGMO). Robin Sawka, BioCentury Staff Blackstone Group Ribometrix Inc. Dyne Therapeutics Inc. Annexon Inc. Mission Therapeutics Ltd. Autolus Therapeutics plc Disc Medicine Inc. Akouos...
BioCentury | Jan 29, 2020
Company News

Management tracks: Century Therapeutics, Passage, Forbion, Bavarian, Disc, Biocartis, QuantuMDx and more

...Zika and norovirus vaccines at the vaccine unit of Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK). Disc Medicine Inc....
BioCentury | Oct 30, 2019
Emerging Company Profile

Disc Medicine: Seeking Iron Balance via Hepcidin

...round with participation by Access Biotechnology and founding investing Atlas Venture, which seeded Cambridge, Mass.-based Disc Medicine Inc....
...data for the two programs, which each represent multibillion dollar opportunities, Bitterman said. COMPANY PROFILE Disc Medicine Inc....
Items per page:
1 - 3 of 3